Prediabetes rarely shows up in absence reports. It does not trigger immediate claims spikes. It does not create dramatic clinical events overnight.
But it is widespread, and it is advancing quietly.
In the Netherlands alone, an estimated 1.3 million people aged 40–75 are living with prediabetes, many unaware of it. Roughly half will go on to develop diabetes over time.
For employers, this is far from a marginal concern. It represents a growing pipeline risk inside your workforce, one that does not announce itself until the damage is already compounding.
The financial drag you don't see
Chronic disease already accounts for up to 80% of healthcare spending in the EU. It reduces labour participation, increases sick leave, accelerates early retirement, and steadily undermines productivity. Prediabetes sits directly upstream of this cost curve.
Progression rates from prediabetes to diabetes range between 5% and 10% per year. Once diabetes develops, hospitalisations increase, mental health burden rises, and long-term claim severity escalates. A workforce with unmanaged metabolic risk today is a claims problem in three to five years.
What appears as stable healthcare cost today can become a structural liability within three to five years.
For HR leaders, insurers, and corporate decision-makers, the question is not whether this risk exists inside your workforce. It is whether it is being identified early enough to act on.
Why early detection changes the equation
Workplace health assessments provide a powerful opportunity. Evidence shows that the workplace is a feasible setting for early detection of prediabetes and the promotion of preventive lifestyle change.
In the same European occupational cohort, 36% of workers with prediabetes reverted to normoglycaemia during follow-up when risk factors were addressed. That reversion does not happen by accident, it happens through structured, sustained support.
The economic case is equally clear. European analyses show that every €1 invested in employee health can generate more than €2 in economic return. Some estimates suggest returns as high as €14 through reduced healthcare costs and improved productivity.
The challenge is not screening alone. The real challenge, the one most corporate health programmes fail to solve, is what happens after identification.
The missing piece: behaviour change as medicine
Prediabetes is reversible. But reversing it requires more than awareness. It requires sustained, structured behaviour change, and behaviour change, at population scale, is where most corporate wellness programmes fall short.
The science is unambiguous. Medication manages symptoms. Behaviour change addresses causes. Nutrition, physical activity, stress, and sleep are not lifestyle add-ons; they are the primary levers of metabolic health. Programmes that treat them as such produce materially different outcomes.
England's NHS Diabetes Prevention Programme, the world's largest national prevention initiative of its kind, offers the clearest evidence of what becomes possible when lifestyle intervention is delivered with genuine clinical rigour. Independent analysis confirms that programme completers show a 47% lower odds of developing type 2 diabetes at 24 months compared to non-completers, alongside an average weight loss of 3.6 kg and a clinically meaningful HbA1c reduction of 2.04 mmol/mol. A University of Manchester study found that referral to the programme was associated with a 20% reduction in diabetes progression risk relative to comparable patients not referred. Across a randomised controlled trial of a digital lifestyle coaching programme in Denmark, participants achieved 4.2 kg mean weight loss versus 1.5 kg in standard care, with comparable outcomes to traditional face-to-face delivery.
These outcomes are not produced by generic wellness apps or passive nudge campaigns. They are produced by programmes built on validated behavioural science frameworks, delivered by qualified health coaches; dieticians, nutritionists, psychologists, with consistent clinical oversight and measurable goals from the very first session.
The broader evidence base reinforces this. A meta-analysis of 50 randomised controlled trials found that structured lifestyle interventions reduced type 2 diabetes incidence by 25% in high-risk populations. A workplace coaching study found incident diabetes cases running at less than a third of expected levels among participants — 24 observed cases versus 74 expected.
The architecture matters as much as the intention. Programmes that combine personalised coaching, evidence-based content, continuous engagement, and clinical accountability deliver outcomes that static health benefit packages simply cannot match.
What this means for your health strategy
Prediabetes does not disrupt operations today. It erodes value slowly in rising claims, in reduced output, in the compounding cost of conditions that were preventable.
Leaders who focus only on acute claims data will miss the upstream drivers of future cost and productivity loss. Those who embed early detection and structured digital behaviour programmes into their corporate health strategy position themselves differently.
They shift from managing chronic disease to preventing it. And that is where sustainable ROI begins.
At Liva Healthcare, we design scalable evidence-based health programmes for employers and insurers built around qualified coaching, clinically proven interventions, and outcomes that are measured from day one. Whether you are building a prevention programme from the ground up, or adding structured chronic condition support to what you already offer, we can help you close the gap between identification and meaningful change.
Ready to understand what prediabetes risk looks like inside your workforce? Talk to our team now.
